Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Janus Henderson

Janus Henderson Venture Fund Class C (JVTCX)

Ticker JVTCX · · Holdings as of Jun 30, 2026

Expense ratio
1.96%$196/yr per $10k
Net assets
$3.6Ball share classes
Holdings
175

Bottom line

Is JVTCX a good fund? The bottom line

JVTCX is the Class C share class of Janus Henderson Venture Fund, an actively managed large blend mutual fund from Janus Henderson.

Annual fees run 1.96% — about $196 a year on every $10,000 invested, more expensive than 92% of large blend funds we track.

With $3.6 billion in net assets and 175 holdings, its largest position is Glaukos Corp. (2.6%) and the top 10 make up 20.1% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.96%)
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What JVTCX invests in

Janus Henderson Venture Fund seeks capital appreciation.

The Fund pursues its investment objective by investing at least 50% of its net assets in small-sized companies. The Fund may also invest in larger companies with strong growth potential. Small-sized companies are defined by portfolio management as those companies whose market capitalization falls within the 12-month capitalization range of the Russell 2000 Growth Index at the time of purchase. Market capitalization is a commonly used measure of the size and value of a company. The market capitalizations within the index will vary, but as of September 30, 2025, they ranged from approximately $4 million to $21.31 billion. The Fund may invest in shares of companies through initial public offerings and secondary offerings. Portfolio management applies a bottom-up approach in choosing investments. In other words, portfolio management looks at companies one at a time to determine if a…

From the fund's prospectus (filed Jan 28, 2026).

What JVTCX costs

On a $10,000 investment, JVTCX's 1.96% expense ratio costs about $196 a year. The prospectus estimates $2,105 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full JVTCX fee table →

JVTCX top 10 holdings

#Holding% of fund
1Glaukos Corp.2.59%
2Ligand Pharmaceuticals, Inc.2.41%
3Perimeter Solutions, Inc.2.19%
4SPX Technologies, Inc.2.12%
5Revolution Medicines, Inc.1.99%
6Tower Semiconductor Ltd.1.89%
7CECO Environmental Corp.1.87%
8Legence Corp.1.73%
9Casey's General Stores, Inc.1.70%
10Janus Henderson Cash Liquidity Fund LLC1.64%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 20.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to JVTCX

More funds like JVTCX →

JVTCX FAQ

What is the expense ratio of JVTCX?
JVTCX's expense ratio is 1.96%, which works out to about $196 a year for every $10,000 invested. The prospectus estimates total costs of $2,105 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is JVTCX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.96%); 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does JVTCX hold?
JVTCX's largest holdings are Glaukos Corp. (2.6%), Ligand Pharmaceuticals, Inc. (2.4%), Perimeter Solutions, Inc. (2.2%), SPX Technologies, Inc. (2.1%), Revolution Medicines, Inc. (2.0%). It holds 175 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Does JVTCX have a sales load?
No. JVTCX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages JVTCX?
JVTCX is offered by Janus Henderson through Janus Investment Fund.